Direct healthcare costs of non-metastatic castration-resistant prostate cancer in Italy.

ABSTRACT:

Objectives

The management of non-metastatic castration-resistant prostate cancer (nmCRPC) is rapidly evolving; however, little is known about the direct healthcare costs of nmCRPC. We aimed to estimate the cost-of-illness (COI) of nmCRPC from the Italian National Health Service perspective.

Methods

Structured, individual qualitative interviews were carried out with clinical experts to identify what healthcare resources are consumed in clinical practice. To collect quantitative estimates of healthcare resource consumption, a structured expert elicitation was performed with clinical experts using a modified version of a previously validated interactive Excel-based tool, EXPLICIT (EXPert eLICItation Tool). For each parameter, experts were asked to provide the lowest, highest, a

SUBMITTER: Borsoi L 

PROVIDER: S-EPMC11574549 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature